Danaher Corporation’s (DHR) Buy Rating Reaffirmed at Cowen and Company
Cowen and Company reissued their buy rating on shares of Danaher Corporation (NYSE:DHR) in a research report report published on Wednesday. They currently have a $90.00 price target on the conglomerate’s stock.
A number of other brokerages have also recently weighed in on DHR. Zacks Investment Research cut shares of Danaher Corporation from a buy rating to a hold rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reiterated a neutral rating and set a $83.00 price target on shares of Danaher Corporation in a research note on Tuesday, September 26th. BidaskClub upgraded shares of Danaher Corporation from a sell rating to a hold rating in a research note on Wednesday, July 19th. J P Morgan Chase & Co reiterated an overweight rating and set a $95.00 price target on shares of Danaher Corporation in a research note on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the stock a buy rating in a research note on Friday, July 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $92.62.
Danaher Corporation (DHR) opened at 87.63 on Wednesday. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62. The company’s 50-day moving average is $85.07 and its 200-day moving average is $84.19. The firm has a market capitalization of $60.88 billion, a P/E ratio of 27.97 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $0.90 EPS. On average, analysts predict that Danaher Corporation will post $3.95 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/08/danaher-corporations-dhr-buy-rating-reaffirmed-at-cowen-and-company.html.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 17.83%.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the transaction, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold 71,496 shares of company stock valued at $5,916,223 in the last quarter. Company insiders own 12.20% of the company’s stock.
Large investors have recently bought and sold shares of the business. Honeywell International Inc. purchased a new position in Danaher Corporation during the 2nd quarter valued at about $25,317,000. Israel Discount Bank of New York purchased a new position in Danaher Corporation during the 1st quarter valued at about $209,000. Eastern Bank increased its holdings in Danaher Corporation by 4,291.1% during the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock valued at $10,802,000 after acquiring an additional 125,086 shares in the last quarter. DE Burlo Group Inc. increased its holdings in Danaher Corporation by 17.8% during the 1st quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock valued at $11,242,000 after acquiring an additional 19,900 shares in the last quarter. Finally, Perkins Coie Trust Co grew its holdings in shares of Danaher Corporation by 2.0% during the second quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock worth $2,484,000 after buying an additional 586 shares in the last quarter. Hedge funds and other institutional investors own 75.68% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.